World AMR Congress

INNOVATE.
COLLABORATE.
COMMERCIALIZE.

Bringing together pharma, biotech, hospitals, Government and their partners to discuss the world’s most important health issue.  

 

 

 

 

FACING A GLOBAL HEALTH CRISIS

 

The World AntiMicrobial Resistance Congress USA gathers C-level decision makers from government, funding agencies, pharma, academia, hospitals, labs, and payers to discuss the urgent need for new antibiotics. President Obama has outlined his 5-year action plan to fight AMR and is seeking to double the AMR funding to $1.2B, but the bigger challenge is how to deliver these actions.

This 2-day conference presents solutions through key notes, case study presentations, expert opinion and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma and academia, in the AMR discussion. This is the 2-day exhibition and conference you cannot afford to miss.

Dx and target discovery

Infection prevention and non-traditional antibiotics

Clinical development

Pitch and partner

Sustainable business approaches to AMR antibiotic development

GAIN Act, QIDP and market authorization

Commercialization and reibursement

 

 

" The evolution of antibiotic resistance is now occurring at an alarming rate and is outpacing the development of new countermeasures capable of thwarting infections in humans. "

President Barack Obama

Meet last year's experts

 

The World Anti-Microbial Resistance Congress 2015 brought all of the greatest minds in the antimicrobial field together to tackle this very issue. It’s time to stop talking about the problem and start discussing solutions, which is why we brought in Pharma, academia and the government.

 

  • Barry Eisenstein at World Anti-Microbial Congress US 2016
    Barry Eisenstein
    Distinguished Physician and Antimicrobials
    Merck & Co.
    Brian Woolhouse at World Anti-Microbial Congress US 2016
    Brian Woolhouse
    VP, Customer Business
    Merck
  • Joe Larsen at World Anti-Microbial Congress US 2016
    Joe Larsen
    Deputy Director
    BARDA
    Michael Dudley at World Anti-Microbial Congress US 2016
    Michael Dudley
    Senior Vice President of Research and Development and Chief Scientific Officer
    The Medicines Company
  • Manos Perros at World Anti-Microbial Congress US 2016
    Manos Perros
    President & CEO
    Entasis Therapeutics
    Sumathi Nambiar at World Anti-Microbial Congress US 2016
    Sumathi Nambiar
    Director, Division of Aniti-Infective Products
    FDA
  • Ribhi Shawar at World Anti-Microbial Congress US 2016
    Ribhi Shawar
    Branch Chief, Division of Microbiology
    CDRH OIVD FDA
    David Melnick at World Anti-Microbial Congress US 2016
    David Melnick
    Vice President, Clinical Development
    Actavis
  • Susan Coller-Monarez at World Anti-Microbial Congress US 2016
    Susan Coller-Monarez
    Asst. Director, National Health Security and International Affairs
    Office Of Science And Technology Policy- White House
    Dr Prabhavathi Fernandes at World Anti-Microbial Congress US 2016
    Dr Prabhavathi Fernandes
    President and CEO
    Cempra
  • Hasan Jafri at World Anti-Microbial Congress US 2016
    Hasan Jafri
    Director, COMBACTE Magnet
    Innovative Medicines Initiative
    Dr Rosemarie Aurigemma at World Anti-Microbial Congress US 2016
    Dr Rosemarie Aurigemma
    Chief Biodefense Drug Development Section
    Nih
  • Brian Bachmann at World Anti-Microbial Congress US 2016
    Brian Bachmann
    Associate Professor of Chemistry
    Vanderbilt University
    Miriam Barlow at World Anti-Microbial Congress US 2016
    Miriam Barlow
    Associate Professor
    University of California Merced
  • Mark Benedyk at World Anti-Microbial Congress US 2016
    Mark Benedyk
    President & CEO
    Telephus Medical Llc
    Roger Beuerman at World Anti-Microbial Congress US 2016
    Roger Beuerman
    Chief Scientific Officer
    SinSa Labs Inc.
  • Samuel Bozzette at World Anti-Microbial Congress US 2016
    Samuel Bozzette
    Vice President of Medical Affairs, Americas
    Biomerieux Inc
    Eric Brown at World Anti-Microbial Congress US 2016
    Eric Brown
    Professor, Department of Biochemistry and Biomedical Sciences
    McMaster University
  • Christopher Dowson at World Anti-Microbial Congress US 2016
    Christopher Dowson
    Head, Infectious Disease Research Group
    University of Warwick
    Michael Draper at World Anti-Microbial Congress US 2016
    Michael Draper
    Senior Director, External Science and Partnering
    Sanofi
  • Paul Dunman at World Anti-Microbial Congress US 2016
    Paul Dunman
    Principal Investigator
    University of Rochester Medical Center
    Slava Epstein at World Anti-Microbial Congress US 2016
    Slava Epstein
    Professor
    Northeastern University
  • Dr Ian Friedland at World Anti-Microbial Congress US 2016
    Dr Ian Friedland
    Chief Medical Officer
    Achaogen
    Ms Thale Jarvis at World Anti-Microbial Congress US 2016
    Ms Thale Jarvis
    Chief Scientific Officer
    Crestone Inc
  • Mark Jones at World Anti-Microbial Congress US 2016
    Mark Jones
    Head of Project Management
    Basilea Pharmaceutica Ltd
    Randall Kincaid at World Anti-Microbial Congress US 2016
    Randall Kincaid
    Senior Scientific Officer, National Institute of Allergy and Infectious Diseases
    NIH
  • Dr Jane Knisely at World Anti-Microbial Congress US 2016
    Dr Jane Knisely
    Program Officer, Bacteriology and Mycology Branch, NIAID
    National Institutes of Health - N.I.H.
    Ankit Mahadevia at World Anti-Microbial Congress US 2016
    Ankit Mahadevia
    Chief Executive Officer
    Spero Therapeutics
  • Dr Andres McAllister at World Anti-Microbial Congress US 2016
    Dr Andres McAllister
    Chief Scientific Officer
    Debiopharm International S.A.
    Dr Krishna Menon at World Anti-Microbial Congress US 2016
    Dr Krishna Menon
    Chief Scientific Officer
    Cellceutix CORP
  • Mark Miller at World Anti-Microbial Congress US 2016
    Mark Miller
    Member Of The Management Committee;Chief Medical Officer
    Biomerieux , Inc.
    Dr Eszter Nagy at World Anti-Microbial Congress US 2016
    Dr Eszter Nagy
    Co-Founder, President and CSO
    Arsanis Inc
  • Prof Kevin Outterson at World Anti-Microbial Congress US 2016
    Prof Kevin Outterson
    Professor of Health Law, Bioethics and Human Rights
    Boston University School of Law
    Blaž Petrič at World Anti-Microbial Congress US 2016
    Blaž Petrič
    Business Developer
    IMMT
  • Blaine Pfeifer at World Anti-Microbial Congress US 2016
    Blaine Pfeifer
    Associate Professor of Chemical & Biological Engineering
    State University of New York at Buffalo
    John Powers at World Anti-Microbial Congress US 2016
    John Powers
    Assistant Clinical Professor of Medicine
    George Washington University
  • Laurence Rahme at World Anti-Microbial Congress US 2016
    Laurence Rahme
    Associate Professor of Surgery
    Massachusetts General Hospital
    Jose Senna at World Anti-Microbial Congress US 2016
    Jose Senna
    Researcher
    Bio-Manguinhos/Fiocruz
  • David Shlaes at World Anti-Microbial Congress US 2016
    David Shlaes
    Manager
    Antibiotics - The Perfect Storm
    Ms Carolyn Shore at World Anti-Microbial Congress US 2016
    Ms Carolyn Shore
    Officer of Antibiotic Resistance Project
    The Pew Charitable Trusts
  • Mr Nathan Stasko at World Anti-Microbial Congress US 2016
    Mr Nathan Stasko
    President and Co Founder
    Novan Therpeutics
    Ms Melissa Stundick at World Anti-Microbial Congress US 2016
    Ms Melissa Stundick
    Branch Chief and Broad Spectrum Antimicrobials Program
    United States Department of Health and Human Services
  • Michael Yeaman at World Anti-Microbial Congress US 2016
    Michael Yeaman
    Professor of Medicine, David Geffen School of Medicine at UCLA, and Chief, Division of Molecular M
    UCLA David Geffen School of Medicine
    Mr Zhengyu Yuan at World Anti-Microbial Congress US 2016
    Mr Zhengyu Yuan
    Chief Executive Officer
    MicuRx Pharmaceuticals Inc

 

" [AMR] is an increasingly serious threat to global public health that requires action across all government sectors and society. "

World Health Organization

Why Sponsor?

Forge new partnerships

Generate new leads

World AntiMicrobial Resistance Congress USA

Build brand presence

Promote new services

SPONSOR NOW
 

 

Take a look at the sponsorship brochure

It helps explain how you can get involved with World AntiMicrobial Resistance Congress USA 2016.  


GET YOUR COPY HERE


 
 

" We’re in the post-antibiotic era. There are patients for whom we have no therapy, and we are literally in a position of having a patient in a bed who has an infection, something that five years ago even we could have treated, but now we can’t. "

Dr. Arjun Srinivasan, Centers for Disease Control and Prevention (CDC)

Register Now

THIS CONFERENCE WILL SELL OUT!
Early registration and partner discounts available.
Click below for the full list of ticket options...

 

REGISTER NOW

 

Error processing SSI file